Nuzenio

Stock Titan Allogene

Stock Titan Allogene entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Allogene Therapeutics (ALLO) stake: Belldegrun group reports 3.9% ownership - Stock TitanStock Titan · Sat, 08 Aug 2026 02:12:07 GMTState Street Corporation (ALLO) discloses 5.5% beneficial stake in Allogene - Stock TitanStock Titan · Fri, 07 Aug 2026 12:33:35 GMTCellectis (NASDAQ: CLLS) reports H1 2026 loss but $169M cash runway - Stock TitanStock Titan · Thu, 06 Aug 2026 20:36:20 GMTAllogene sets Aug. 12 update on cancer and autoimmune disease - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMTAllogene Reports No Minimal Residual Disease in 7 of 12 Cema-Cel Patients - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 02:12:07 GMTAllogene Therapeutics (ALLO) stake: Belldegrun group reports 3.9% ownership - Stock Titan
Fri, 07 Aug 2026 12:33:35 GMTState Street Corporation (ALLO) discloses 5.5% beneficial stake in Allogene - Stock Titan
Thu, 06 Aug 2026 20:36:20 GMTCellectis (NASDAQ: CLLS) reports H1 2026 loss but $169M cash runway - Stock Titan
Tue, 04 Aug 2026 12:30:00 GMTAllogene sets Aug. 12 update on cancer and autoimmune disease - Stock Titan
Wed, 29 Jul 2026 07:00:00 GMTAllogene Reports No Minimal Residual Disease in 7 of 12 Cema-Cel Patients - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Allogene.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.